Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002)

被引:7
作者
Ascoli, V. [1 ]
Minelli, G. [2 ]
Kanieff, M. [2 ]
Crialesi, R. [3 ]
Frova, L. [3 ]
Conti, S. [2 ]
机构
[1] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00161 Rome, Italy
[2] Ist Super Sanita, I-00161 Rome, Italy
[3] ISTAT, Serv Sanita & Assistenza, I-00198 Rome, Italy
关键词
CKS; multiple-causes-of-death; mortality; death certificate; epidemiology; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; OF-DEATH DATA; TRANSPLANT RECIPIENTS; PRIMARY NEOPLASM; UNITED-STATES; RISK-FACTORS; CANCERS; HUMAN-HERPESVIRUS-8; SEROPREVALENCE; INDIVIDUALS;
D O I
10.1038/sj.bjc.6605265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Little information is available on the causes of death among persons with classic Kaposi's sarcoma (CKS). METHODS: We conducted a population-based study in Italy to identify deceased persons with CKS and the underlying causes of death among them, by reviewing multiple-causes-of-death records. Standardised mortality ratios (SMRs) and 95% confidence intervals were calculated to compare the distribution of causes to that among the same-age general population of deceased persons. The geographical distribution was also evaluated. RESULTS: Of the 946 deaths among persons with CKS, 65.9% were attributable to non-neoplastic conditions and 21.9% to malignancies. For 12.2%, no lethal pathology was identified and CKS was considered as the underlying cause. In 90% of these cases, there was visceral/nodal involvement, therapy-related complications, or neoplastic cachexia. Among persons with CKS who died of other causes, an excess for lymphoid malignancies emerged (SMR = 4.40) ( chronic lymphocytic leukaemia (11.03), non-Hodgkin's lymphoma (4.22), Hodgkin's lymphoma (11.80), and multiple myeloma (2.3)), balanced by a deficit for all solid cancers (0.56), with a marked deficit for lung cancer (0.41). We found an excess for respiratory diseases ( chronic obstructive pulmonary disease (1.86)) and genitourinary diseases (chronic renal failure (6.47)). There was marked geographical heterogeneity in the distribution of deaths. CONCLUSIONS: Though referring specifically to Italy, the results are informative for other countries and populations and all cases of CKS in general. British Journal of Cancer ( 2009) 101, 1085-1090. doi:10.1038/sj.bjc.6605265 www.bjcancer.com Published online 25 August 2009 (C) 2009 Cancer Research UK
引用
收藏
页码:1085 / 1090
页数:6
相关论文
共 41 条
[1]   A case of Kaposi's sarcoma following treatment of membranoproliferative glomerulonephritis and a review of the literature [J].
Agbaht, Kemal ;
Pepedil, Funda ;
Kirkpantur, Alper ;
Yilmaz, Rahmi ;
Arici, Mustafa ;
Turgan, Cetin .
RENAL FAILURE, 2007, 29 (01) :107-110
[2]   Risk Factors for Classical Kaposi Sarcoma on a Population-based Case-control Study in Sicily [J].
Anderson, Lesley A. ;
Lauria, Carmela ;
Romano, Nino ;
Brown, Elizabeth E. ;
Whitby, Denise ;
Graubard, Barry I. ;
Li, Yan ;
Messina, Angelo ;
Gafa, Lorenzo ;
Vitale, Francesco ;
Goedert, James J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (12) :3435-3443
[3]   Distribution of mosquito species in areas with high and low incidence of classic Kaposi's sarcoma and seroprevalence for HHV-8 [J].
Ascoli, V. ;
Facchinelli, L. ;
Valerio, L. ;
Zucchetto, A. ;
Dal Maso, L. ;
Coluzzi, M. .
MEDICAL AND VETERINARY ENTOMOLOGY, 2006, 20 (02) :198-208
[4]  
Ascoli V, 2002, HAEMATOLOGICA, V87, P339
[5]   High incidence of classic Kaposi's sarcoma in Mantua, Po Valley, Northern Italy (1989-1998) [J].
Ascoli, V ;
Belli, S ;
Benedetti, M ;
Trinca, S ;
Ricci, P ;
Comba, P .
BRITISH JOURNAL OF CANCER, 2001, 85 (03) :379-382
[6]   RISK OF OTHER CANCERS FOLLOWING KAPOSIS-SARCOMA - RELATION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BIGGAR, RJ ;
CURTIS, RE ;
COTE, TR ;
RABKIN, CS ;
MELBYE, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (04) :362-368
[7]  
Brambilla L, 2003, EUR J DERMATOL, V13, P83
[8]  
BRAMBILLA L, 1994, CANCER-AM CANCER SOC, V74, P2873, DOI 10.1002/1097-0142(19941115)74:10<2873::AID-CNCR2820741021>3.0.CO
[9]  
2-1
[10]  
Breslow NE., 1987, STAT METHODS CANC RE, V1